Microbot Medical MBOT Institutional Ownership

Updated Oct 10, 2026

Microbot Medical Inc. (NASDAQ:MBOT) had 71 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• These investors held 16.88% of Microbot Medical's outstanding shares at the end of Q2 2026, down from 20.49% in Q1 2026.
• Total holdings of MBOT shares fell 17.60% from Q1 2026, and the holder count rose 44.90% from Q2 2025.
• Of these 71 holders, 36 added to their positions, 13 reduced their stakes and 22 left their positions unchanged.
• The aggregate institutional position in Microbot Medical was 11.34Mn shares at the end of Q2 2026, down 2.42Mn from the prior quarter and up 7.11Mn from a year earlier.
• As of June 30, 2026, the biggest holder of Microbot Medical was Vanguard Capital Management LLC with 2.91Mn shares, or 4.33% of shares outstanding.
• Holders that added the most shares of Microbot Medical in Q2 2026 were American Century Companies Inc (+80.9K shares), Geode Capital Management, LLC (+75.44K shares), Marshall Wace, LLP (+60.92K shares), Group One Trading LLC (+59.87K shares) and AlphaCentric Advisors LLC (+50K shares).
• The largest position reductions in MBOT for Q2 2026 were by Susquehanna International Group, LLP (-398.48K shares), Millennium Management LLC (-368.44K shares), Squarepoint Ops LLC (-105.31K shares), Morgan Stanley (-66.45K shares) and Qube Research & Technologies Ltd (-59.21K shares).
• Per Business Quant data, the 10 largest holders of Microbot Medical at the end of Q2 2026 were Vanguard Capital Management LLC (2.91Mn shares), Mitsubishi UFJ Asset Management Co., Ltd. (1.27Mn shares), BlackRock, Inc. (902.41K shares), Geode Capital Management, LLC (836.27K shares), UBS Group AG (806.85K shares), DnB Asset Management AS (677.5K shares), Stifel Financial Corp (589.92K shares), Marshall Wace, LLP (541.96K shares), Susquehanna International Group, LLP (525.83K shares) and Vanguard Fiduciary Trust Co (431.03K shares).